Nisa Investment Advisors
XENT

Nisa Investment Advisors’s Intersect ENT, Inc XENT Stock Holding History

Nisa Investment Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,230
Closed -$208K – 2054
2019
Q3 		$208K Buy
+12,230
New +$223K ﹤0.01% 1310

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Nisa Investment Advisors's XENT Position: Q4 2019 in Review

Nisa Investment Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2019, closing a stake of 12,230 shares — an estimated $208K sold.

Nisa Investment Advisors first reported a position in XENT in Q3 2019 and held it in 1 quarter. The position peaked at $208K in Q3 2019. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

  • Nisa Investment Advisors reported no remaining Intersect ENT, Inc position as of Q4 2019 after selling out during the quarter.
  • Nisa Investment Advisors sold 12,230 Intersect ENT, Inc shares in Q4 2019, an estimated $208K.
  • Nisa Investment Advisors first reported a position in Intersect ENT, Inc in Q3 2019 and held it in 1 quarter.
  • Nisa Investment Advisors's Intersect ENT, Inc position peaked at $208K in Q3 2019.
  • 120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Nisa Investment Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.